The present disclosure provides certain combination therapy technologies that are particularly useful for treating one or more diseases, disorders, or conditions that may be related to abnormal metabolism. In some embodiments, provided technologies provides combinations of TCA cycle acids and ketone bodies. In some embodiments, provided technologies provides combinations of TCA cycle acids and other carboxylic acids.
                            本公开提供了某些组合治疗技术,这些技术对于治疗可能与代谢异常有关的一种或多种疾病、失调或病症特别有用。在某些实施方案中,所提供的技术提供了 
TCA 循
环酸和酮体的组合。在某些实施方案中,所提供的技术提供了
TCA循
环酸和其他
羧酸的组合。